Bill Adams
Fortune : 252 428 $ au 31/07/2026
Fortune : 252 428 $ au 31/07/2026
William J.
Adams worked as a Lending Officer at Mellon Bank, NA in 1993.
From 1994 to 1996, worked as a Securities Analyst at Conseco Life Insurance Company of Texas.
Served as Portfolio Manager at Massachusetts Financial Services Co. from 2000 to 2005.
Held the position of Chief Financial Officer, Secretary & Treasurer at AnorMED, Inc. from 1997 to 2006.
Was Chief Financial Officer at CellFor, Inc. from 2008 to 2010.
Served as Chief Financial Officer at Response Biomedical Corp.
in 2012.
Worked as Chief Investment Officer of Global Fixed Income at Massachusetts Financial Services Co. from 2015 to 2024.
Held the role of Chief Financial Officer & Secretary at NervGen Pharma Corp.
from 2020 to 2026.
Also served as Chief Financial Officer at Anandia Laboratories, Inc. Education includes an undergraduate degree from the University of British Columbia in 1988, a graduate degree from Indiana University in 1990, and an MBA from Indiana University in 1991.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
NERVGEN PHARMA CORP. 0,19 % | 14/03/2025 | 155 820 ( 0,19 % ) | 252 428 $ | 31/07/2026 |
| Sociétés | Poste | Fin |
|---|---|---|
| NERVGEN PHARMA CORP. | Directeur Financier/CFO | 15/03/2026 |
Massachusetts Financial Services Co.
Massachusetts Financial Services Co. Investment ManagersFinance MFS focuses on identifying businesses with durable, long-term value through their active investment platform. The firm uses various methods to evaluate securities, including fundamental analysis and quantitative analysis. | Directeur de Recherche - Fxd Inc | 01/01/2011 |
CellFor, Inc.
CellFor, Inc. Agricultural Commodities/MillingProcess Industries Produces and supplies loblolly pine seedlings | Directeur Financier/CFO | 29/04/2010 |
AnorMED, Inc.
AnorMED, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops metal based therapeutics | Directeur Financier/CFO | 09/11/2006 |
Massachusetts Financial Services Co.
Massachusetts Financial Services Co. Investment ManagersFinance MFS focuses on identifying businesses with durable, long-term value through their active investment platform. The firm uses various methods to evaluate securities, including fundamental analysis and quantitative analysis. | Portfolio Manager-Fixed Income | 01/01/2005 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 10 |
|---|---|
Massachusetts Financial Services Co.
Massachusetts Financial Services Co. Investment ManagersFinance MFS focuses on identifying businesses with durable, long-term value through their active investment platform. The firm uses various methods to evaluate securities, including fundamental analysis and quantitative analysis. | Finance |
Mellon Bank, NA
Mellon Bank, NA Regional BanksFinance Provides commercial banking services | Finance |
Response Biomedical Corp.
Response Biomedical Corp. Medical SpecialtiesHealth Technology Develops acute care diagnostic testing products | Health Technology |
AnorMED, Inc.
AnorMED, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops metal based therapeutics | Health Technology |
Indiana University
Indiana University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of British Columbia
University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CellFor, Inc.
CellFor, Inc. Agricultural Commodities/MillingProcess Industries Produces and supplies loblolly pine seedlings | Process Industries |
Conseco Life Insurance Company of Texas
Conseco Life Insurance Company of Texas Life/Health InsuranceFinance Provides life insurance services | Finance |
Anandia Laboratories, Inc.
Anandia Laboratories, Inc. BiotechnologyHealth Technology Produces biotechnology products | Health Technology |
NervGen Pharma Corp.
NervGen Pharma Corp. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops neuroreparative therapeutics and pharmaceutical products for neurological disorders | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national